AEON Biopharma, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
5 PARK PLAZA, IRVINE, CA, 92614
Mailing Address
5 PARK PLAZA, IRVINE, CA, 92614
Phone
(949) 354-6499
Fiscal Year End
1231
EIN
853940478
Financial Overview
FY2025
$60.59M
Total Liabilities
$3.01M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 3 Initial insider ownership report | April 3, 2026 | View on SEC |
| 8-K Current report of material events | April 3, 2026 | View on SEC |
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
| 8-K Current report of material events | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 5, 2026 | View on SEC |
| 4 Insider stock transaction report | March 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 19, 2026 | View on SEC |
Annual Reports
10-K
March 30, 2026
- Focused development of ABP-450 for the $3.3 billion U.S. medical botulinum toxin market.
- Strategic pivot to prioritize cervical dystonia trials over migraine research to conserve capital.
Material Events
8-K
Financial Distress
April 3, 2026
High Impact
- Clinical-stage development of ABP-450 continues without operational disruption.
- Company maintains active clinical trials despite exchange compliance challenges.
Related Companies
Companies in the same industry (SIC: 2834)
Aurinia Pharmaceuticals Inc.
AUPH
Pharmaceutical Preparations
Kezar Life Sciences, Inc.
KZR
Pharmaceutical Preparations
Sunshine Biopharma Inc.
SBFM
Pharmaceutical Preparations
Matinas BioPharma Holdings, Inc.
MTNB
Pharmaceutical Preparations
Esperion Therapeutics, Inc.
ESPR
Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.